131 related articles for article (PubMed ID: 37865274)
21. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
[TBL] [Abstract][Full Text] [Related]
22. Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Abel T; Moodley J; Khaliq OP; Naicker T
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430232
[TBL] [Abstract][Full Text] [Related]
23. The mechanism and active compounds of semen
Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
Food Nutr Res; 2021; 65():. PubMed ID: 34908920
[TBL] [Abstract][Full Text] [Related]
24. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.
Badraoui R; Alrashedi MM; El-May MV; Bardakci F
J Biomol Struct Dyn; 2021 Oct; 39(17):6842-6851. PubMed ID: 32752936
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
[TBL] [Abstract][Full Text] [Related]
26. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
27. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
28. NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Samsonia M; Kandelaki M; Baratashvili N; Gvaramia L
Georgian Med News; 2023 Feb; (335):111-118. PubMed ID: 37042600
[TBL] [Abstract][Full Text] [Related]
29. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes.
Zeng FM; Li YW; Deng ZH; He JZ; Li W; Wang L; Lyu T; Li Z; Mei C; Yang M; Dong Y; Jiang GM; Li X; Huang X; Xiao F; Liu Y; Shan H; He H
EMBO Mol Med; 2022 May; 14(5):e14844. PubMed ID: 35362189
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
32. HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer.
Eguchi R; Wakabayashi I
Oncol Rep; 2020 Jul; 44(1):14-28. PubMed ID: 32319650
[TBL] [Abstract][Full Text] [Related]
33. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19.
Borrmann M; Brandes F; Kirchner B; Klein M; Billaud JN; Reithmair M; Rehm M; Schelling G; Pfaffl MW; Meidert AS
Front Immunol; 2023; 14():1129766. PubMed ID: 36776845
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and related molecules in acute lung injury.
Mura M; dos Santos CC; Stewart D; Liu M
J Appl Physiol (1985); 2004 Nov; 97(5):1605-17. PubMed ID: 15475552
[TBL] [Abstract][Full Text] [Related]
35. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
37. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
38. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
39. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
40. Molecular crosstalk between COVID-19 and Alzheimer's disease using microarray and RNA-seq datasets: A system biology approach.
Premkumar T; Sajitha Lulu S
Front Med (Lausanne); 2023; 10():1151046. PubMed ID: 37359008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]